The effect of HIF-1α and HIF-2α ASO treatment on the inflammatory component of the TME in the DEN-induced HCC mouse model was first assessed via flow cytometric analysis of the hepatic macrophage pool. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.